Haichuang Pharmaceutical (688302.SH) announced that Guo Hong, the company's chief medical officer and core technical officer, recently applied to resign from his position due to personal reasons and completed the separation procedure. He will no longer hold any position in the company after leaving his job. When Guo Hong assumed the position of Chief Medical Officer, Dr. XINGHAI LI (Li Xinghai), the company's chief technology officer, took over the work. Dr. XINGHAI LI (Li Xinghai) is the company's senior management and core technical staff. Currently, he is fully responsible for the pre-clinical management of the company's new drug development and all global clinical business management.
海创药业(688302.SH)首席医学官暨核心技术人员郭宏离职
Guo Hong, chief medical officer and core technician of Haichuang Pharmaceutical (688302.SH), left office
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.